New Stock News | Bansun Pharmaceutical and other companies' Hong Kong IPOs have their materials accepted by the CSRC.
The China Securities Regulatory Commission released the "Filing Status Table for Overseas Securities Offering and Listing by Domestic Enterprises (Initial Public Offering and Full Circulation) (as of September 24, 2026)."
The China Securities Regulatory Commission (CSRC) has released the "Filing Status Table for Overseas Securities Offering and Listing by Domestic Enterprises (Initial Public Offering and Full Circulation)". Among them, the CSRC listing filing status for the Hong Kong IPOs of Bansun Pharmaceutical and other companies is "Accepted".
Related Articles
Guotai Haitong: Life insurance growth picked up from January to September, while property insurance growth remained steady; the insurance sector's valuation is expected to still have room for recovery.
CITIC SEC: What signals do CDS spreads reveal amid the AI financing boom?
Shenwan Hongyuan Group: Short-term market cost-effectiveness has significantly improved; oversold rebound small and micro-cap stocks and themes have higher elasticity.
Guotai Haitong: Life insurance growth picked up from January to September, while property insurance growth remained steady; the insurance sector's valuation is expected to still have room for recovery.
CITIC SEC: What signals do CDS spreads reveal amid the AI financing boom?
Shenwan Hongyuan Group: Short-term market cost-effectiveness has significantly improved; oversold rebound small and micro-cap stocks and themes have higher elasticity.
